（原标题：21专访｜北大汇丰马琳琳：深圳应强化"创新试验田"角色） 21世纪经济报道记者 雷若馨 深圳报道 2025年，诺贝尔经济学奖回归对"创新驱动增长"的本源问题、"十五五"规划建议落子"提高资本市场制 度包容性"。如今的金融钥匙，究竟要打开怎样的一把锁？ 而解开这道题的关键，在于读懂金融如何从服务"已知"转向发现"未知"。 "深圳最大的创新，在于构建了一个'把不确定性资本化'的制度生态。"近日，在接受21世纪经济报道记 者采访时，北京大学汇丰金融研究院副院长马琳琳指出。 她长期从事机构投资者行为研究，主要方向包括共同基金、对冲基金运作机制及行为金融学理论。同 时，其研究团队持续关注养老金融领域，为应对人口老龄化提供理论支持。 在马琳琳看来，"提高资本市场制度包容性"的核心是引导资本从"短期博弈"的投机游戏中离开，转 向"长期发现"价值的新赛场。她从机构投资者行为调整的三大趋势谈起，系统阐释了如何通过制度之渠 将流动性引向"五篇大文章"的广阔领域。 此外，她还一语道破了"五篇大文章"中养老金融本质：它既是居民未来的"每月可领"，也是国家未来 的"长期耐心资本"。 马琳琳：引导的话，其实国家已经在做。修渠引 ...

剑南春天猫"双11"交易量再创佳绩 新浪财经"酒价内参"重磅上线 知名白酒真实市场价尽在掌握 转自：中国质量报 伴随消费理念升级和电商运营日趋精细化，酒业"双11"不再是单纯的价格血拼，而是基于品牌影响力与消费体验升级的综合较量。 2025年"双11"，剑南春天猫平台官方旗舰店斩获白酒行业交易总量第一名，剑南春与中国国家博物馆联名打造的丙午马年生肖酒在"双11"期间引发全网抢购 热潮。 业内人士表示，这一亮眼成绩不仅体现了剑南春的品牌实力与市场认可度，还印证了其以文化赋能品牌、以创新驱动增长的战略正确性，为助力行业穿越周 期持续贡献力量。 携手国博IP赋能 打造马年生肖新顶流 今年"双11"，剑南春携手中国国家博物馆联名打造的丙午马年生肖酒，集名酒底蕴、文物活化、生肖文化、审美艺术和时代精神于一体，成为剑南春天猫平 台官方旗舰店的流量担当。 作为中国国家博物馆"文物活化合作伙伴"，剑南春秉持文化传承的使命，以馆藏珍品"隋·光正随人十二生肖铜镜"为设计灵感，融入清代宫廷画师郎世宁 《十二生肖瓷板画》午马图，实现文物价值活态传承，与当代消费者形成跨越时空的情感共鸣。 创新产品运营模式，适配多元消费场景。剑南春丙午 ...

Financial Data and Key Metrics Changes - Underlying revenue growth for Q3 was 5%, consistent with H1 run rate, driven by sports medicine and advanced wound management [2][3] - Revenue for the quarter was $1.5 billion, with a reported growth of 6.3% due to a 130 basis point tailwind from foreign exchange [5] - Free cash flow guidance raised from over $600 million to around $750 million, reflecting improved working capital discipline and operational efficiencies [3][12] Business Line Data and Key Metrics Changes - Orthopedics grew 4.1% on an underlying basis, with strong performance in hips in the US offsetting softer knee sales [5][7] - Trauma and extremities grew 7.5%, with strong contributions from Evos plating system and Atos shoulder [8] - Advanced wound management grew 6%, with advanced wound care growing 1.1% and Bioactives up 12.2% [9][10] Market Data and Key Metrics Changes - US market grew 5.5%, while other established markets grew 3.9% and emerging markets grew 5.4% [5] - Excluding China, underlying revenue growth was 6.4%, with joint repair growth at 13% [3][9] - China headwinds are beginning to abate, with expectations of a gradual recovery [3][8] Company Strategy and Development Direction - Innovation remains central to growth, with over half of growth coming from products launched in the last five years [13][15] - The company is focused on cash and capital efficiency, expecting further margin expansion beyond 2025 [12][42] - Upcoming capital markets day will outline the next phase of growth and midterm priorities [16][17] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in meeting revenue guidance for Q4, supported by new customer integrations and product placements [21][31] - The impact of Medicare reimbursement changes is anticipated to be a headwind for Advanced Wound Management sales in 2026 [10][41] - Management acknowledged the ongoing portfolio rationalization in US knees, which has led to some volume loss but remains a strategic focus [27][39] Other Important Information - The company launched several new products, including the Alevi Complete Care dressing and the Legion medial stabilized knee [14][15] - The company is committed to building a sustainable business in China, evaluating product lines for investment [43] Q&A Session Summary Question: Concerns about revenue guidance and Q4 performance - Management remains confident in Q4 revenue guidance, citing strong sales funnel and new customer integrations [21][31] Question: US knees performance and portfolio rationalization impact - Management acknowledged the gap between US knees and market performance, attributing it to ongoing portfolio rationalization [27][39] Question: Margin guidance and headwinds for 2026 - Management expects margin expansion despite headwinds from knees and hips, with specific guidance to be provided at the capital markets day [40][42] Question: Pricing trends and competitive landscape - Management noted a return to more normalized pricing levels in orthopedics, with expectations of continued competitive positioning [64][65] Question: Other recon performance and expectations for Q4 - Management expressed optimism about Q4 performance in other recon, citing strong placements and utilization [71]

Financial Data and Key Metrics Changes - Graphic Packaging's sales for Q3 2025 were $2.2 billion, with adjusted EBITDA of $383 million and an adjusted EBITDA margin of 17.5%. Adjusted EPS was $0.58 [5][22][24] - Year-on-year volumes were down 2%, but the company outperformed most markets served [10][12] Business Line Data and Key Metrics Changes - The innovation platform contributed approximately $52 million in sales, representing about 2% of total sales [35] - The company reported a modest deceleration in packaging sales, down approximately 2% year-over-year, excluding the effect of foreign exchange [14] Market Data and Key Metrics Changes - The grocery volumes showed pressure, with upper-income consumers spending differently while lower-income consumers cut back due to rising food prices [9][10] - Food and household products remained steady, while beverage and food service markets were weaker [13][18] Company Strategy and Development Direction - The Waco facility is a critical investment aimed at enhancing the company's competitive advantage in recycled paperboard, expected to ramp up production over 12-18 months [8][9] - The company is transitioning from Vision 2025 to Vision 2030, focusing on free cash flow generation [5][28] Management's Comments on Operating Environment and Future Outlook - Management acknowledged challenges in the consumer packaging environment but expressed confidence in the company's ability to improve margins as demand normalizes [23][24] - The company plans to focus on cost control and inventory reduction to navigate the current market dynamics [24][25] Other Important Information - The company repurchased approximately 6.8 million shares year-to-date, reducing shares outstanding by 2.3% in 2025 [23] - A $400 million delayed draw term loan was secured to manage upcoming bond maturities, providing financial flexibility [27] Q&A Session Summary Question: Did the end markets track expectations in Q3? - Management clarified that there was no share loss; customer purchasing patterns affected volumetric performance, with the company outperforming overall market trends [35][36] Question: Confidence in Waco's EBITDA contribution for next year? - Management expressed high confidence in Waco delivering the expected $80 million EBITDA contribution, with adjustments based on market volumes [37][38] Question: Opportunities for productivity improvement? - Management highlighted various levers to improve efficiency, including capital expenditure reduction and inventory management [44][46] Question: Trends in the food service market? - Management noted that fast casual dining is under pressure, while quick service restaurants are performing better, with innovation expected to drive volume growth [50][51] Question: Impact of competitive price pressure on SBS and CUK? - Management confirmed that they have not lost market share and emphasized the cost advantages of coated recycled paperboard over bleached alternatives [60][61] Question: Clarification on Waco's start-up costs? - Management indicated that the start-up costs of $65-$75 million are primarily operating costs incurred during the facility's ramp-up, with a portion expected to carry into 2026 [80][83]

Financial Data and Key Metrics Changes - Order intake grew by 8%, marking the fourth consecutive quarter of improvement, reflecting robust demand and disciplined execution [4][5] - Comparable sales growth increased to 3% year-on-year, with adjusted EBITDA margin expanding by 50 basis points to 12.3% despite tariff impacts [4][5][24] - Year-to-date order book is up 6% compared to last year, with free cash flow expected to be between EUR 0.2 billion and EUR 0.4 billion for the full year [5][30] Business Line Data and Key Metrics Changes - Personal Health segment saw an 11% increase in comparable sales, driven by strong demand across grooming, oral healthcare, and childcare [21][22] - Connected Care achieved 5% comparable sales growth, supported by strong monitoring solutions, while Diagnostic Imaging experienced a modest decline [20][21] - Diagnosis and Treatment (D&T) comparable sales improved by 1% year-over-year, with Image-Guided Therapy showing solid growth [18][19] Market Data and Key Metrics Changes - North America remains a key growth driver, with strong demand for hospital patient monitoring solutions and a double-digit order intake growth [6][16] - In China, tender activity is gradually increasing, but centralized procurement is causing longer processing times and tougher competition [17][44] - Capital spending remains stable in Europe and Latin America, while India and Saudi Arabia continue to invest in healthcare and digitization [17] Company Strategy and Development Direction - The company is focused on driving measurable improvements in collaboration with global regulators and reinforcing trust among stakeholders [14] - Continued investment in innovation is expected to fuel growth, with a strong emphasis on AI to enhance productivity across various segments [26] - The company plans to showcase progress under its 2023 to 2025 plan at the upcoming capital markets day in February 2026 [31] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving full-year commitments, with expectations for comparable sales growth in the range of 1%-3% [30][31] - The impact of tariffs is anticipated to be between EUR 150 million and EUR 200 million for the full year, with ongoing mitigation efforts [24][30] - Management remains cautious about the near-term outlook for China but is optimistic about long-term growth potential [17][44] Other Important Information - The company passed six out of nine FDA inspections with no observations, reflecting progress in quality systems [12][13] - Adjusted diluted EPS from continued operations rose to EUR 0.36, up 13% year-over-year, driven by higher earnings [27] - Free cash flow performance improved significantly, with EUR 172 million reported for the quarter [28] Q&A Session Summary Question: Future price hikes and inflation impact - Management indicated that price increases may occur due to inflationary pressures, but growth remains a critical focus [34] Question: Contribution of China to Personal Health sales - Management clarified that there was no restocking effect in China, and broad-based growth was observed across all businesses [35] Question: Maintaining productivity momentum into 2026 - Management expressed confidence in continuing productivity improvements, with a focus on mitigating tariff impacts [36] Question: Order timing in D&T and diagnostic imaging sales outlook - Management noted that order timing is uneven, with expectations for improvement in Q4 [38] Question: Impact of Section 232 on imaging and connected care - Management is actively engaging in discussions regarding tariffs and is preparing to mitigate any potential impacts [40][41] Question: GE's decision to sell its Chinese business - Management highlighted competitive positioning and innovation as key differentiators in the market [49] Question: Currency headwinds for next year - Management expects some currency headwinds in Q4, which will be factored into future guidance [50] Question: Downgrade of D&T sales guidance - Management confirmed that the downgrade is primarily related to China, with longer conversion cycles also impacting sales [54][56]

Core Insights - Align Technology, Inc. is a leading global medical device company specializing in Invisalign clear aligners and iTero intraoral scanners, competing in the dental and orthodontics industry [1] - The company has a market capitalization of approximately $10.15 billion, indicating its significant presence in the industry [4][6] - Align's stock has shown volatility with a 52-week range of $246.19 to $122, reflecting both challenges and growth potential [4][6] Financial Performance - During the Q3 2025 earnings call, Align's stock price was $140.08, marking a 6.19% increase or $8.17 from the previous day [3] - The stock price fluctuated between $139.39 and $150.78 during the trading day, indicating active investor interest [3] - Jonathan Block from Stifel Nicolaus set a price target of $200 for Align Technology, suggesting a potential increase of about 41.29% from the stock price of $141.55 at that time [2][6] Market Sentiment - Analysts, including Jonathan Block, reiterated a buy rating for Align Technology, reflecting positive sentiment regarding the company's future prospects [5] - The company's innovative products and strategic direction have positioned it favorably within the dental and orthodontics sector, driving growth and investor interest [1][5]

Financial Data and Key Metrics Changes - Consolidated sales for Q3 2025 were $582 million, up over 9% year over year, driven by strong organic contribution and pricing actions [5][9] - Adjusted fully diluted earnings per share increased by 11% to $1.30 for Q3 2025 compared to $1.17 for Q3 2024 [9] - Gross profit was $208.7 million, up from $189.7 million in the prior year, with gross profit as a percentage of net sales at 35.9%, an increase of 20 basis points [9][10] - Operating income rose to $85.1 million, a 16% increase from $73.5 million in the prior year, with an operating income margin of 14.6%, up from 13.8% [10][11] Business Segment Data and Key Metrics Changes - Water Systems sales increased by 11% year over year, with strong performance in Europe, the U.S., and Canada, despite softer housing starts [6][11] - Energy Systems sales were up nearly 15% year over year, with significant growth in the U.S., Europe, and India, and a healthy order intake [7][14] - Distribution segment sales increased by 3.4%, marking the strongest pricing performance in over two years, driven by both price and volume [8][13] Market Data and Key Metrics Changes - U.S. and Canadian Water Systems sales were up 9%, with large dewatering equipment sales increasing by 38% [11][12] - Energy Systems sales in the U.S. and Canada increased by 11%, while sales outside these regions rose by 26% [14] - The groundwater market in the U.S. was relatively flat, but the company expects low single-digit growth due to high replacement rates [44] Company Strategy and Development Direction - The company is focused on growth acceleration, resilient margins, strategic investments, and top-tier talent, with ongoing innovation and capacity expansion [17][19] - New product launches in the pressure-boosting market are expected to drive growth, with a total addressable market in the high hundreds of millions of dollars [35] - The company is expanding its global footprint with a new factory in Izmir, Turkey, to enhance capabilities in Eastern Europe and the Middle East [19][68] Management's Comments on Operating Environment and Future Outlook - Management anticipates a subdued market in the U.S. and Canada for 2026, but expects volume growth driven by innovation and strong channel relationships [24][26] - The company is optimistic about growth opportunities outside the U.S., particularly in Latin America and emerging markets [25][42] - Management highlighted the importance of maintaining strong cost discipline and strategic pricing to navigate macroeconomic challenges [4][10] Other Important Information - The company announced a quarterly cash dividend of $0.265, payable on November 20 [16] - The effective tax rate for the quarter was 27%, up from 24% in the prior year, influenced by increased foreign earnings [15] Q&A Session Summary Question: Outlook for end markets moving into next year - Management expects a flattish market in the U.S. and Canada but anticipates volume growth due to strong channel relationships and new product introductions [24][26] Question: Energy Systems margin profile - Management indicated that tariffs were a significant factor affecting margins, with expectations for incremental price increases in the coming year [28][29] Question: Backlog growth in Energy Systems - The backlog is up year over year, with favorable growth prospects for 2026 driven by ongoing investments in fuel and infrastructure [41][42] Question: Groundwater performance in North America - The groundwater market is expected to remain stable, with low single-digit growth anticipated due to high replacement rates [44] Question: Distribution business margin improvements - Management highlighted strategic cost management and improved efficiency as key drivers for margin enhancements in the Distribution segment [62][63]

Financial Data and Key Metrics Changes - In Q3 2025, the company generated $99 million of adjusted free cash flow with a conversion rate of 36.8% [14][15] - Adjusted EBITDA for Q4 is expected to be between $274 million and $287 million, improving upon prior levels [19] - The net leverage ratio is approximately 0.5 times, with liquidity around $1.6 billion [18] Business Line Data and Key Metrics Changes - North America saw a slight sequential increase due to seasonal recovery in Canada, but U.S. land operations declined [5][6] - Latin America improved revenues by 10% sequentially, primarily driven by Mexico, although revenues are still down approximately 60% year-over-year [6][8] - The MENA and Asia regions posted another quarter of sequential growth, led by the UAE, Qatar, Australia, and Thailand [6][7] Market Data and Key Metrics Changes - The company noted rising pricing pressure in several markets, particularly in commodity services, with the Middle East being the most affected [27] - Customer spending trends for the next year remain uncertain, with expectations of continued softness in the first half of 2026 [11][12] - OPEC Plus is adding supply back to the market, increasing pressure on the global oil supply-demand balance [11] Company Strategy and Development Direction - The company is focused on cost optimization and has reduced headcount by over 2,000, lowering annualized personnel expenses by more than $145 million [12][16] - A multi-year cost optimization program is in place to achieve sustainable productivity gains through technology and lean processes [22] - The company is committed to not chasing market share at the expense of unfavorable cash outcomes, focusing instead on margin expansion [28] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism about slight improvements in Mexico and the potential for growth in the MENA-Asia region [6][11] - The overall market remains soft, with expectations of year-on-year comparisons being down in the first half of 2026 [11][12] - The company is confident in its ability to manage through the current cycle and emerge stronger [23] Other Important Information - The company has paid four quarterly dividends of $0.25 per share and repurchased approximately $193 million worth of shares over the past five quarters [8] - A significant contract was awarded in Brazil for $147 million, showcasing the strength of the company's technology [9] - The company is undergoing a full-scale ERP cloud-based implementation expected to enhance operational efficiencies [74] Q&A Session Summary Question: Pricing pressure in certain markets - Management noted pricing pressure primarily in commodity services, particularly in the Middle East, but not as much in differentiated product lines [27][28] Question: Recovery in Saudi Arabia - Management indicated that Saudi Arabia is expected to see a rebound in activity, primarily driven by gas, with oil activity also contributing [33][34] Question: Mexico's payment situation - Management expressed cautious optimism regarding payments from Mexico, noting recent positive developments and a payment received [40][42] Question: DRE margins improvement - Management attributed margin improvements to stabilization in Latin America and increased activity levels, particularly in the Middle East [46][47] Question: Free cash flow guidance - Management indicated that the $100 million free cash flow guidance includes conservatism, with potential for higher outcomes depending on payments from Mexico [51][54] Question: Overall spend levels for 2026 - Management suggested that the first half of 2026 may be soft, with a rebound expected in the second half, particularly in offshore markets [60][62] Question: Cost optimization impact on margins - Management discussed both cyclical and structural aspects of cost optimization, emphasizing the importance of maintaining margins despite market headwinds [66][68] Question: Impact of intelligent completions technology - Management expressed excitement about new technologies, which are expected to improve margins and cash flow conversion [70][71] Question: ERP implementation benefits - Management highlighted that the ERP implementation will rethink business processes and is expected to enhance margins and operational efficiencies [74]

Core Points - The Fourth Plenary Session of the 20th Central Committee of the Communist Party of China is being held from October 20 to 23, focusing on the formulation of the 15th Five-Year Plan, which will outline China's development blueprint for the next five years [1][2] - The new Five-Year Plan is expected to provide direction and key objectives for China's economic development, influencing global development and creating more opportunities for the world [1][2] - The session emphasizes China's confidence in development and strategic determination, showcasing a commitment to innovation-driven growth and inclusive modernization [2][3] Economic Development - The 15th Five-Year Plan (2026-2030) will be discussed, covering China's medium to long-term economic development path and policy priorities [1][2] - The achievements during the 14th Five-Year Plan period demonstrate China's steady economic growth despite global economic turbulence, particularly in renewable energy and electric vehicles [3] Global Impact - The decisions made during the Fourth Plenary Session are anticipated to have global implications, marking a critical turning point in China's economic transformation towards advanced technology and innovation [2][3] - The Belt and Road Initiative is entering a new phase of modernization and high-quality development, expected to create more opportunities for participating countries [3]

Core Viewpoint - The article discusses the transformative impact of generative AI across various sectors and highlights the concept of "creative destruction" as a driving force for innovation and economic growth, referencing the recent Nobel Prize in Economics awarded to three scholars for their contributions to this field [3][5]. Group 1: Nobel Prize Winners and Their Contributions - The Nobel Prize in Economics was awarded to Philippe Aghion, Peter Howitt, and Joel Mokyr, emphasizing the significance of "innovation-driven growth" [5]. - Aghion and Howitt developed a mathematical model of "creative destruction," transforming Joseph Schumpeter's philosophical ideas into practical insights for economic growth [12][13]. - Their model illustrates that economic growth results from a series of "micro-revolutions," where each innovation enhances productivity while simultaneously phasing out outdated technologies [16]. Group 2: Innovation Dynamics - Aghion and Howitt's research reconciles two prevailing views on innovation: Schumpeter's belief in market power as a driver of innovation and Kenneth Arrow's view that competition fosters innovation [14][15]. - They introduced the "inverted U-shaped curve" to explain the relationship between competition and innovation, suggesting that moderate competition fosters the best environment for innovation [18][23]. - The balance of fear and hope is identified as the core driver of innovation, where moderate competition creates a sense of urgency for existing firms while providing opportunities for challengers [24]. Group 3: Policy Implications - Aghion argues that government should create an environment conducive to growth rather than directly generating it, emphasizing the importance of maintaining competitive tension [25][28]. - The article suggests that antitrust policies should not aim to eliminate large companies but ensure they face competition, while subsidies should distribute innovation risks across society [28][31]. - The integration of industrial and competition policies is essential for fostering innovation, allowing for long-term R&D support alongside open market access [31].